AzTrials
AzTrials

Childhood AggressionDBT-CNCT01547052

Adapting Dialectical Behavior Therapy for Children in Residential Care

A study testing DBT for children and Enhanced Supportive-Educational therapy in people with Childhood Aggression, run by Weill Medical College of Cornell University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

I: Conduct Pilot Randomized Clinical Trial of Dialectical Behavior Therapy for children (DBT-C) in residential as compared with Treatment-As-Usual (TAU) (60 children in DBT-C and 60 children in the comparison condition). Read more about this study

Who is it for?
Ages 6 to 12 years, men only
Conditions the study is for
Childhood Aggression
What is being tested?
DBT for children and Enhanced Supportive-Educational therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
1 siteUnited States
Study dates
Apr 2011to Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • Men only
  • No healthy volunteers
  • Child

Who may be able to join

  • age between 6 years 0 months and 12 years 11 months;
  • male;
  • in residential care at Green Chimneys;
  • projected length of stay is at least 8 months.

Who cannot join

  • pervasive developmental disorder;
  • psychotic disorder;
  • mental retardation; (all as per psychiatric evaluation at Green Chimneys);
  • in care or custody of the Department of Social Services (DSS);
  • caregivers do not speak English.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Green Chimneys Residential Treatment Center

    Brewster, New York, 10509-0719

Other trials in United States

About this study

Official title: Adapting Dialectical Behavior Therapy for Children in Residential Care: Pilot Randomized Clinical Trial With Children With Severe Emotional and Behavioral Dysregulation

I: Conduct Pilot Randomized Clinical Trial of Dialectical Behavior Therapy for children (DBT-C) in residential as compared with Treatment-As-Usual (TAU) (60 children in DBT-C and 60 children in the comparison condition).

II: Finalize therapist training manuals and educational materials to guide selection, training, and supervision of treatment providers.

Read the detailed description

Specific Aim 1: Examine feasibility of DBT-C by evaluating response rate in treatment attendance, treatment satisfaction, and any differences in these rates by groups.

Hypothesis 1: DBT-C will be equivalent to TAU in attendance rate and will have significantly greater treatment satisfaction rating by subjects, as well as by therapists and milieu staff.

Specific Aim 2: Examine efficacy of DBT-C as compared to TAU in reducing internalizing and externalizing symptoms.

Hypothesis 2: Children in DBT-C condition as compared to TAU will have significantly fewer internalizing and externalizing symptoms.

Specific Aim 3: Examine efficacy of DBT-C in improving adaptive coping, emotion regulation, risk taking, and social skills, and reducing depression.

Hypothesis 3: Children in DBT-C Training condition as compared to TAU will have significantly greater improvement in adaptive coping skills, emotion regulation, risk taking and impulsivity and social skills, and reducing depressive symptoms.

Specific Aim 4: Examine efficacy of DBT-C in reducing the frequency of critical incidents.

Hypothesis 4: Children in DBT-C condition as compared to TAU will have significantly fewer critical incidents, including psychiatric hospitalization, emergency room visits, total number of days inpatient, suicidal ideations and attempts, self-harm behaviors, sexual acting out, running away, stealing, police involvement, etc.

Being tested
DBT for children, Enhanced Supportive-Educational therapy
Keywords
DBT, child, emotion regulation, behavior problems
Medical subject headings
Maple syrup urine disease, type 2, Emotional Regulation, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DBT for childrenBehavioural

    Also called Dialectical Behavior Therapy adapted for Children

    intervention consists of weekly individual 45 min. sessions, twice per week 60 min. group sessions, and every other week 90 min. sessions with parents

  • Enhanced Supportive-Educational therapyBehavioural

    Also called Enhansed TAU

    weekly individual 45 min sessions, twice per week 60 min. group sessions and every other week parent sessions.

Study groups in NCT01547052
Study groupRoleWhat they receive
DBT for childrenExperimentalDialectical Behavior Therapy adapted for children
Receives: Behavioral: DBT for children
Enhanced Supportive-Educational TherapyActive comparatorEnhanced Treatment-As-Usual, including supportive-educational model, cognitive-behavioral skills and parent management training
Receives: Behavioral: Enhanced Supportive-Educational therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attendance Form

    Measured: post-treatment at 30 weeks

Secondary outcomes (13)
  1. Balloon Analog Risk Task

    Measured: pre-treatment, week 6, 12, 18, 24, 30 of treatment and at 3 and 6 months follow-up

  2. Mood and Feelings Questionnaire

    Measured: pre-treatment, weeks 6, 12, 18, 24 and 30 of treatment at at 3 and 6 months follow-up

  3. Emotion Regulation Checklist

    Measured: pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up

  4. Children's Coping Strategies Checklist

    Measured: pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up

  5. Pleasure Scale for Children

    Measured: pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up

  6. Social Skills Rating Scale

    Measured: pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up

  7. Therapy Satisfaction Questionnaire

    Measured: week 30

  8. Therapist Satisfaction Scale

    Measured: week 30

  9. Milieu Staff Satisfaction Questionnaire

    Measured: every 6 months

  10. Incident Report

    Measured: pre-treatment, weeks 6, 12, 18, 24 and 30 of treatment at at 3 and 6 months follow-up

  11. Psychosocial Treatment Compliance Scale

    Measured: week 30

  12. Child Behavior Checklist

    Measured: at pre-treatment, 6, 12, 18, 24, 30 weeks of treatment, and at 3 and 6 months follow-up

  13. Difficulty with Emotion Regulation Scale

    Measured: pre-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2012 (estimated)
  2. Study startApr 2011
  3. Primary completionAug 2015
  4. Study completionSep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01547052
Sponsor's protocol ID
1012007764
Acronym
DBT-C
Status last verified
Jul 2018
First submitted
1 Mar 2012
Last updated
23 Jul 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing DBT for children and Enhanced Supportive-Educational therapy in people with Childhood Aggression, run by Weill Medical College of Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attendance Form (time frame: post-treatment at 30 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in